Bristol-Myers Squibb Company
Utility Patents
Last updated:
List of all Bristol-Myers Squibb Company patents 334 in total
| Status | Patent |
|---|---|
Grant | Utility: Fibronectin based scaffold proteins Filling date: 6 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Antisense oligonucleotides targeting alpha-synuclein and uses thereof Filling date: 6 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Substituted indole compounds useful as inhibitors of TLR7/8/9 Filling date: 6 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Spiroheptanyl hydantoins as rock inhibitors Filling date: 6 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Aminoimidazopyridazines as kinase inhibitors Filling date: 6 Sep 2025 Issue date: 13 Sep 2022 |
Grant | Utility: Fast-off rate serum albumin binding fibronectin type III domains Filling date: 6 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: 6-azaindole compounds Filling date: 6 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Aryl and heteroaryl substituted indole compounds Filling date: 6 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Amide substituted indole compounds useful as TLR inhibitors Filling date: 6 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Method to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids Filling date: 6 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Compounds useful as immunomodulators Filling date: 6 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Anti-GITR antibodies for cancer diagnostics Filling date: 6 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Fibronectin binding domains with reduced immunogenicity Filling date: 6 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Stabilized fibronectin based scaffold molecules Filling date: 6 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: 2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Methods of minimizing glycoprotein agregation in CHO cell production Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Apelin receptor agonists and methods of use Filling date: 6 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Methods for treating costimulation blockade resistant rejection Filling date: 6 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Pyrazole n-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Multicyclic compounds as farnesoid X receptor modulators Filling date: 6 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof Filling date: 6 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Antisense oligonucleotides targeting alpha-synuclein and uses thereof Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Supramolecular high affinity protein-binding system for purification of biomacromolecules Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Cyclohexyl acid pyrazole azoles as LPA antagonists Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Compositions and methods of treating cancer Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Antibodies against CD73 and uses thereof Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Filling date: 6 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: High pH protein refolding methods Filling date: 6 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: PET imaging with PD-L1 binding polypeptides Filling date: 6 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 24 May 2022 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 24 May 2022 |
Grant | Utility: Synthetic process Filling date: 6 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Methods of treating colorectal cancer Filling date: 6 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Cyclohexyl acid triazole azoles as LPA antagonists Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Cyclohexyl acid isoxazole azines as LPA antagonists Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Cyclohexyl acid pyrazole azines as LPA antagonists Filling date: 6 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Amino indole compounds useful as TLR inhibitors Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Phenylacetamides as inhibitors of rock Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Combination of TIM-4 antagonist and PD-1 antagonist and methods of use Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Diazaindole compounds Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-.alpha. modulators Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatment Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Showing 1 to 50 of 334 patents.